- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
TMPRSS2 Enhanced Vero E6 Cell Line (CAT#: VCeL-Lsx001)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VCeL-Lsx001 |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- Recombinant clonal stable Vero E6 cell line constitutively expressing full length human TMPRSS2 (Genbank #NM_005656.4.)
- Quantity
- 2×106 cells/ml
- Target
- SARS-CoV-2
- Applications
- Effective tools for studying COVID-19 drugs and vaccines.
- Cell Type
- TMPRSS2 Enhanced Cell Lines
- Organism
- Vero E6 cells
- Growth Properties
- Adherent
- Fluid Renewal
- 2 to 3 times / week
- Form
- Frozen Cryovial
- Biosafety Level
- 1
- Alternative Names
- TMPRSS2 enhanced VeroE6 Cell Line; TMPRSS2-Vero E6 Recombinant Cell Line
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.